Amarnath & Amarnath. Scavenging 4-oxo-2-nonenal. Chem Res Toxicol 28, 1888-1890 (2015). View abstract.
Davies et al. Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity. Biochemistry 45, 15756-15767 (2006). View abstract.
Davies et al. Treatment with a ?-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice. J Alzheimers Dis 27, 49-59 (2011). View abstract.
Fuller, J. C., Jr. et al. In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate. Food Chem Toxicol 121, 541-548, doi:10.1016/j.fct.2018.09.047 (2018). View abstract.
Fuller et al. Subchronic (90-day) repeated dose toxicity study of 2-hydroxybenzylamine acetate in rats. Regul Toxicol Pharmacol 99, 225-232, doi:10.1016/j.yrtph.2018.09.025 (2018). View abstract.
Fuller et al. Subchronic (90-day) repeated dose oral toxicity study of 2-hydroxybenzylamine acetate in rabbit. Regul Toxicol Pharmacol 100, 52-58, doi:10.1016/j.yrtph.2018.10.017 (2018). View abstract.
Pitchford et al. Acute and 28-day repeated dose toxicity evaluations of 2-hydroxybenzylamine acetate in mice and rats. Regul Toxicol Pharmacol, 98, 190-198 (2018). View abstract.
Pitchford et al. First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers. BMC Pharmacol Toxicol 20, 1, (2019). View abstract.
Pitchford et al. Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial. BMC Pharmacol Toxicol 21, 3, (2020). View abstract.
Nguyen et al. Scavengers of reactive ?-ketoaldehydes extend Caenorhabditis elegans lifespan and healthspan through protein-level interactions with SIR-2.1 and ETS-7. Aging 8, 1759-1780 (2016). View abstract.
Zagol-Ikapite et al. Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers. J Lipid Res 56, 2196-2205 (2015). View abstract.